RE: Real world stories: Novo Nordisk and Cancer Research UK drive digital breakthroughs with Microsoft Power Platform
[quote user="Power Platform Communities"]
Hear from members of the Clinical Development Digital Innovation team who are leading Power Platform adoption at Novo Nordisk, and inspiring other areas of the business too. Their solutions leverage Dataverse and the full breadth of premium capabilities in the platform.
James Beckenham talks about how Power Apps and Power Automate integrated in Teams provides scalable business solutions to staff across Cancer Research UK, streamlining processes and increasing collaboration among researchers.
https://mediastream.microsoft.com/events/2021/2105/MBAS21/Images/MBAS_Gallery_Placeholder_Graphic.jpg
OD308
[/quote]
Good news.
Although still under-utilized, benzimidazoles, especially albendazole, may have a promising future in cancer treatment. It can be used along with other drugs to prevent resistance and enhance the effectiveness of various anticancer therapies.
In order to bring this potential into practice, there is a need for more clinical trials with advanced participants, especially targeting solid and refractory tumors. Such studies can confirm the role of these drugs in cancer treatment as a part of combination therapy and possibly its role as monotherapy for certain types of cancers.
For more information on research in cancer therapy, visit our Cancer Research section. There you will find a list of topics related to cancer treatments and related subjects. Also read through our blogs, they might answer your questions. If you want to share your opinion or discuss a relevant topic with our experts, feel free to leave a comment below the post. We’d be glad to hear from you and provide assistance in any way we can.
Source: https://www.fenbendazole.org/2019/12/19/well-known-anthelminthic-drug-shows-promising-result-in-cancer-treatment/